Biologics

OligoMedicines

News

Investors

Extranet

 

Expertise. Innovation. Commitment.

Avecia is a leading private biotechnology company focused on the development and manufacture of innovative biotechnology-based medicines. With a long history of technological innovation, we work closely with our customers - who are typically biotechnology or pharmaceutical companies - helping them achieve fast progress into, and through, the clinical development programme.

We have two main operating business units:

Avecia's two main operating business units.

In addition our headquarters operation is located in Manchester, UK.

Whilst the two business units operate independently, the enthusiasm, knowledge and skills of our people are common across both, enabling our customers to realise the potential of their exciting new medical treatments for serious diseases such as cancer and heart disease.


Search      
Please type in a keyword or phrase

Recruitment
Click on a location below to view current job vacancies within Avecia:

News

05/08/2008
New Appointments at Avecia Biologics

25/07/2008
Listen to audio podcast of Andy Topping, PhD, R&D Director of Early Phase Development, recorded by BioPharm International at the BIO International Convention in San Diego, 16-20 June 2008

25/06/2008
MolMed and Avecia announce pharmaceutical development and manufacturing agreement

To review all news items
click here

Legal Statement and Disclaimer

Home | Site Map | Contact Us

Click here for Biologics Click here for DNA Medicines